Sven Hoffner
Impact in
- Infectious Diseases top 0.2%
- Tuberculosis Research and Epidemiology
- Molecular Medicine top 5%
- Antibiotic Resistance in Bacteria
Papers in
-
- Tuberculosis Research and Epidemiology 108
- HIV/AIDS Research and Interventions 1
- Epidemiology 27
- Mycobacterium research and diagnosis 27
- Co-authors
- Gunilla Källenius (27 shared papers)Emma Huitric (3 shared papers)Koen Andries (2 shared papers)Peter Verhasselt (2 shared papers)Jim Werngren (17 shared papers)Stefan B. Svenson (16 shared papers)Jérôme Guillemont (1 shared paper)Didier de Chaffoy de Courcelles (1 shared paper)
- Journals
- Antimicrobial Agents and Chemotherapy (15 papers)Journal of Clinical Microbiology (11 papers)Journal of Antimicrobial Chemotherapy (8 papers)European Journal of Clinical Microbiology & Infectious Diseases (8 papers)PLoS ONE (5 papers)
- Partner nations
- SwedenUnited StatesUnited Kingdom
In The Last Decade
Sven Hoffner
135 papers receiving 7.2k citations
Sven Hoffner's Hit Papers
Peers
Comparison fields: 5 of 117
- Infectious Diseases 5.4k
- Molecular Medicine 157
- Applied Microbiology and Biotechnology 55
- Epidemiology 712
- Microbiology 110
Countries citing papers authored by Sven Hoffner
This map shows the geographic impact of Sven Hoffner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sven Hoffner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sven Hoffner more than expected).
Fields of papers citing papers by Sven Hoffner
This network shows the impact of papers produced by Sven Hoffner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sven Hoffner. The network helps show where Sven Hoffner may publish in the future.
Co-authors
The 25 scholars most cited alongside Sven Hoffner, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 135 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | A Diarylquinoline Drug Active on the ATP Synthase of Mycobacterium tuberculosis Hit paper breakdown → | 2004 | 1830 |
| 2 | Global Trends in Resistance to Antituberculosis Drugs Hit paper breakdown → | 2001 | 558 |
| 3 | Emergence of New Forms of Totally Drug-Resistant Tuberculosis Bacilli Hit paper breakdown → | 2009 | 479 |
| 4 | Evolutionary history and global spread of the Mycobacterium tuberculosis Beijing lineage Hit paper breakdown → | 2015 | 427 |
| 5 | 2012 | 160 | |
| 6 | 2009 | 156 | |
| 7 | 2007 | 145 | |
| 8 | 2014 | 135 | |
| 9 | 2011 | 131 | |
| 10 | 2012 | 130 | |
| 11 | 2006 | 127 | |
| 12 | 2018 | 117 | |
| 13 | 2009 | 99 | |
| 14 | 2003 | 97 | |
| 15 | 2010 | 92 | |
| 16 | 2013 | 89 | |
| 17 | 2008 | 83 | |
| 18 | 1999 | 82 | |
| 19 | 2011 | 81 | |
| 20 | 2009 | 79 |
About Sven Hoffner
Sven Hoffner is a scholar working on Infectious Diseases, Epidemiology, Microbiology, Physical and Theoretical Chemistry and General Dentistry, having authored 135 papers that have together received 7.7k indexed citations. Recurring topics across this work include Tuberculosis Research and Epidemiology (108 papers), Mycobacterium research and diagnosis (27 papers), Antimicrobial Peptides and Activities (2 papers), Synthesis and Biological Evaluation (2 papers), thermodynamics and calorimetric analyses (2 papers), Bacillus and Francisella bacterial research (1 paper), Cancer therapeutics and mechanisms (1 paper) and HIV/AIDS Research and Interventions (1 paper). The work is most often cited by research in Infectious Diseases (5.4k citations), Molecular Medicine (157 citations), Applied Microbiology and Biotechnology (55 citations), Epidemiology (712 citations) and Microbiology (110 citations). Sven Hoffner has collaborated with scholars based in Sweden, United States and United Kingdom. Frequent co-authors include Gunilla Källenius, Emma Huitric, Koen Andries, Peter Verhasselt, Jim Werngren, Stefan B. Svenson, Jérôme Guillemont, Didier de Chaffoy de Courcelles, Jean‐Marc Neefs and Hinrich W. H. Göhlmann. Their work appears in journals such as Antimicrobial Agents and Chemotherapy, Journal of Clinical Microbiology, Journal of Antimicrobial Chemotherapy, European Journal of Clinical Microbiology & Infectious Diseases and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.